2025 second_quarter Filing
Q2Income
$20K
Filed
July 17, 2025
Lobbying Activities
Health IssuesView all
Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Budget/AppropriationsView all
Increased funding for longevity research at the National Institutes of Health
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
JOHN GUY